Past Programs List
1996 Summary of the Presentations
| The Kenneth W. G. Brown Memorial Lecture Single Gene Disease – Fact and Fantasy | Katherine Siminovitch MD |
| Coronary Artery Disease – Have we made any impact on long term survival? | Brian Kimball MD |
| Ventricular Tachycardia – Not all the same? – Evaluating and prognosticating the risk | Louise Harris MD |
| Eating Disorders – Associated mortality risk | Allan Kaplan MD |
| Hepatitis C – Assessment and associated Mortality | Jenny Heathcote MD |
| Childhood Cancers – Long term prognosis | Ron D. Barr MD |
| Thrombotic Syndromes – Classification evaluation and prognosis | Richard Jay MD |
| NIDDM:Identifying risk factors that contribute to excess mortality | Anne Kenshole MD |
| Case Management:Disability or ability to work? | David S. L. Brown MD |
| The Design of the Ideal Impai | Michel Lacerte MD |
| Case ClaimsManagement Strategies for Psychological Disabilities – A Medical Perspective | Kenneth Hashman MD |
| A Medical Rehab Model – Preferred Provider Organizations | Lyle Gross MD |
| Objective Evaluation of Physical Disability through Functional Capacity Evaluations | Janet Greenbank Dp. Pt. MHSc |
| ORCHESTRA- Matching job description and analysis of functional capacity. How effective is it? | Sheila Ritcey PhD |
| Epilepsy- New treatments and mortality trends | Joe Bruni MD |
| Methotrexate- How real are the concerns with its use? | Arthur Bookman MD |
| KidneyTransplantation – How has the long term outlook improved? | Carl Cardella MD |
| Debate:Is it the Medical Director’s responsibility to Report Positive HIV tests? | P Miller MD, A Lowden MD |
| Evidence Based Medicine – What is it? How will an understanding of it assist an insurance medical director? | Geoffrey Anderson MD |
| Health Care Reform – Implications to the insurance industry | Robert Brown |
| What is the best way to control escalating Drug costs? | G Hines (PMA) G Ujiye (OPA) J L. Mann (CDMA) |
CLIMOA 2021